Trials / Completed
CompletedNCT02921659
Safety & Efficacy of Nicotinamide Riboside Supplementation for Improving Physiological Function in Middle-Aged and Older Adults
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- University of Colorado, Boulder · Academic / Other
- Sex
- All
- Age
- 55 Years – 79 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the efficacy of supplementation with the Nicotinamide Adenine Dinucleotide (NAD+) precursor compound, Nicotinamide Riboside (NR), for improving physiological function (vascular, motor, and cognitive) in healthy middle-aged and older adults.
Detailed description
Overall, the proposed research project has the long-term potential to influence clinical practice by establishing novel therapies for treating multiple domains of age-associated physiological dysfunction and thereby reducing the risk of clinical disease and disability.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Niagen™ | nicotinamide riboside chloride, 250mg capsules |
| DIETARY_SUPPLEMENT | Placebo | silicified microcrystalline cellulose, vegetarian capsule |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2016-10-01
- Completion
- 2016-10-01
- First posted
- 2016-10-03
- Last updated
- 2016-12-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02921659. Inclusion in this directory is not an endorsement.